Leukotriene Antagonists

DBCAT000910Therapeutic categoryR03DC

A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. A DrugBank category of 8 drugs. 3 of them are approved.

ATC classification: R — RESPIRATORY SYSTEM
R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC — Leukotriene receptor antagonists
Also known as: Antagonists, Leukotriene · Antagonists, Leukotriene Receptor · Leukotriene Receptor Antagonists · Receptor Antagonists, Leukotriene
Drugs: Ibudilast
Montelukast
Pranlukast
SC 41930
Tomelukast
Verlukast
Zafirlukast
Zileuton

What you can answer from here — as of August 24, 2016

8DrugsEach linked to its full drug card

Listed above

18Drug targetsEvery drug–target pair in the class, with bond type

1,957Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Leukotriene Antagonists share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account